Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regulated gene expression in gene therapy.

P W Zoltick1, J M Wilson

  • 1Institute for Human Gene Therapy, University of Pennsylvania, Philadelphia 19104, USA.

Annals of the New York Academy of Sciences
|January 25, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fission yeast myosin-II isoforms assemble into contractile rings at distinct times during mitosis.

Current biology : CB·2001
Same author

Congenital diaphragmatic hernia: where are we and where do we go from here?

Seminars in perinatology·2001
Same author

Pulmonary morbidity in 100 survivors of congenital diaphragmatic hernia monitored in a multidisciplinary clinic.

Journal of pediatric surgery·2001
Same author

A quantitative nonimmunogenic transgene product for evaluating vectors in nonhuman primates.

Molecular therapy : the journal of the American Society of Gene Therapy·2000
Same author

Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections.

Journal of virology·2000
Same author

Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse.

Gene therapy·2000
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
See all related articles

Regulated gene expression systems enhance gene therapy safety and efficacy by controlling transgene levels. This approach allows precise therapeutic targeting, overcoming limitations of traditional gene therapy methods.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • Traditional gene therapy models focus on transgene delivery and stable expression.
  • Improved understanding of gene expression dynamics reveals limitations in achieving optimal therapeutic levels.
  • Suboptimal or supraoptimal transgene expression can compromise safety and efficacy.

Purpose of the Study:

  • To explore the role of regulated gene expression systems in enhancing gene therapy.
  • To investigate how controlled transgene expression can improve safety and therapeutic outcomes.
  • To highlight the potential of pharmacologically regulated gene expression in clinical applications.

Main Methods:

  • Review of current gene therapy models and their limitations.
  • Analysis of techniques enabling regulated transgene expression.

Related Experiment Videos

  • Discussion of the principles behind controlling gene expression timing and levels.

    • Main Results:

    • Regulated gene expression offers enhanced safety by allowing precise control over transgene product levels.
    • Controlled expression can achieve therapeutic efficacy by maintaining expression within optimal thresholds.
    • Pharmacologically regulated systems provide a versatile tool for managing gene therapy outcomes.

    Conclusions:

    • Regulated gene expression is crucial for advancing safe and effective gene therapy.
    • Pharmacologically controlled systems represent an evolving and promising approach for various clinical scenarios.
    • Tailoring gene expression regulation to specific clinical needs is essential for successful gene therapy.